About Procyon Life Sciences Private Limited
Data last updated:
Procyon Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 November 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2006PTC165479. Its GSTIN is 27AAECP0522F1ZU (Maharashtra).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Ajay Dharamshi Virchand (Managing Director) and Rajveer Virchand Dharamshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 404 Remi Bizcourt Opp. Supreme Industries Veera Desai Road Andheri (West)., Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.41 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹26.11 Lakh (net margin 4.1%) and EBITDA of ₹71.94 Lakh (EBITDA margin 11.2%). Revenue has declined at a compounded annual rate (CAGR) of 36% over three years and 16% over five years.
The company is associated with 1 brand: Procyon Life Sciences. As per MCA filings, the company has open charges of ₹2.23 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website procyonlifesciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressE – 404 Remi Bizcourt Opp. Supreme Industries Veera Desai Road Andheri (West)., Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Procyon Life Sciences Private Limited
Procyon Life Sciences operates one associated brand: Procyon Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of active pharmaceutical ingredients and intermediates in Mumbai. | procyonlifesciences.com |
Business Activity of Procyon Life Sciences Private Limited
The main business activity of Procyon Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Procyon Life Sciences Private Limited FY 2025 filings available
Procyon Life Sciences Private Limited reported revenue of ₹6.41 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Procyon Life Sciences Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 2% fall in the latest year. EBITDA fell 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Procyon Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹71.94 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹26.11 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Procyon Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Procyon Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Procyon Life Sciences Private Limited
Procyon Life Sciences has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Dharamshi Virchand | Managing Director | 10 Nov 2006 | 19 Years 11 Months | Current |
| Rajveer Virchand Dharamshi | Director | 01 Feb 2022 | 4 Years 8 Months | Current |
| Seema Ajay Dharamshi | Director | 10 Nov 2006 | 19 Years 11 Months | Current |
Peer Comparison of Procyon Life Sciences Private Limited
Procyon Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Curex Pharma Private Limited | ₹6.46 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | New Delhi, Delhi, India |
| Maa Laboratories Private Limited | ₹6.46 Cr (FY 2019) | •••• | •••• | 28.0% | •••• | Hyderabad, Telangana, India |
| Nutrizo Advancis Healthcare Private Limited | ₹6.45 Cr (FY 2025) | •••• | •••• | 42.0% | •••• | Mumbai, Maharashtra, India |
| Globaux Impex Private Limited | ₹6.45 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Vadodara, Gujarat, India |
| Dolcas Botanosys Private Limited | ₹6.43 Cr (FY 2023) | •••• | •••• | 7.0% | •••• | Delhi, India |
| Procyon Life Sciences Private Limited this company | ₹6.41 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Mumbai, Maharashtra, India |
| Pushti Pharmachem Private Limited | ₹6.41 Cr (FY 2024) | •••• | •••• | -15.0% | •••• | Shajapur, Madhya Pradesh, India |
| Glocal Lifescience Private Limited | ₹6.4 Cr (FY 2017) | •••• | •••• | -27.0% | •••• | Pune, Maharashtra, India |
| Oceanic Laboratories Private Limited | ₹6.4 Cr (FY 2024) | •••• | •••• | 123.0% | •••• | Palghar, Maharashtra, India |
| B H Construction Private Limited | ₹6.39 Cr (FY 2023) | •••• | •••• | 1034.0% | •••• | Mumbai, Maharashtra, India |
| Mannika Biotech Private Limited | ₹6.38 Cr (FY 2024) | •••• | •••• | 182.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Procyon Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Procyon Life Sciences Private Limited
Procyon Life Sciences Private Limited is audited by Bambolkar & Dagia Associates LLP for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Bambolkar & Dagia Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Procyon Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Procyon Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Dec 2017 | Others | ₹2.23 Cr | Open |
Total charge records: 1 View all charges
MSME Payment Delays by Procyon Life Sciences Private Limited
Procyon Life Sciences Private Limited has 7 MSME Form 1 returns on record between 2019 and 2023, listing 9 overdue payments to 3 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (3 of 3)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SNJ Labs Private Limited | •••• | •••• | •••• |
| Sainor Laboratories Private Limited | •••• | •••• | •••• |
| Prism Industries Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 7 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Procyon Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Procyon Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Procyon Life Sciences Private Limited
Procyon Life Sciences Private Limited has 5 board changes on record since 2006: 3 appointments and 2 cessations. The latest: Virchand Laxmichand Dharamshi ceased to be Director on 20 Mar 2023.
Credit Ratings, Litigation & Regulatory Alerts for Procyon Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Procyon Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Procyon Life Sciences Private Limited
Procyon Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECP0522F1ZU | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Procyon Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Procyon Life Sciences Private Limited
Procyon Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 November 2006 (20+ years old) and is registered under CIN U24239MH2006PTC165479.
Procyon Life Sciences reported revenue of ₹6.41 Cr for FY 2025 (down 2% YoY).
Procyon Life Sciences has 3 current directors:
- Ajay Dharamshi Virchand - Managing Director
- Rajveer Virchand Dharamshi - Director
- Seema Ajay Dharamshi - Director
Procyon Life Sciences reported a net profit of ₹26.11 Lakh (net margin 4.1%) and EBITDA of ₹71.94 Lakh (EBITDA margin 11.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Procyon Life Sciences is -36% over three years and -16% over five years. In the latest year (FY 2025) revenue fell 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Procyon Life Sciences is 27AAECP0522F1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Procyon Life Sciences is U24239MH2006PTC165479. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Procyon Life Sciences was incorporated on 10 November 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Procyon Life Sciences by revenue are Curex Pharma Private Limited, Maa Laboratories Private Limited, Nutrizo Advancis Healthcare Private Limited, Globaux Impex Private Limited, Dolcas Botanosys Private Limited and 5 more, all in the Pharma industry (Formulations).
Virchand Laxmichand Dharamshi ceased to be Director on 20 Mar 2023. Rajveer Virchand Dharamshi ceased to be Additional Director on 28 Sep 2022. Rajveer Virchand Dharamshi was appointed as Director on 01 Feb 2022. Procyon Life Sciences has 5 board changes on record in total.
Procyon Life Sciences has 7 MSME Form 1 returns on record between 2019 and 2023, listing 9 overdue payments to 3 micro and small suppliers. The latest return was filed on 21 Oct 2023.
Procyon Life Sciences can be reached through the website procyonlifesciences.com. Its registered office is in Mumbai, Maharashtra, India.